These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31609195)

  • 1. Identification of E6AP-independent degradation targets of HPV E6.
    Vats A; Thatte J; Banks L
    J Gen Virol; 2019 Dec; 100(12):1674-1679. PubMed ID: 31609195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
    Drews CM; Case S; Vande Pol SB
    PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.
    Massimi P; Shai A; Lambert P; Banks L
    Oncogene; 2008 Mar; 27(12):1800-4. PubMed ID: 17934525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
    Tomaić V; Pim D; Banks L
    Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
    Vats A; Trejo-Cerro O; Massimi P; Banks L
    J Virol; 2022 Aug; 96(16):e0066322. PubMed ID: 35916535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin ligase E6AP mediates nonproteolytic polyubiquitylation of β-catenin independent of the E6 oncoprotein.
    Kuslansky Y; Sominsky S; Jackman A; Gamell C; Monahan BJ; Haupt Y; Rosin-Arbesfeld R; Sherman L
    J Gen Virol; 2016 Dec; 97(12):3313-3330. PubMed ID: 27902311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of HPV E6 oncoproteins with specific proteasomal subunits.
    Tomaić V; Ganti K; Pim D; Bauer C; Blattner C; Banks L
    Virology; 2013 Nov; 446(1-2):389-96. PubMed ID: 24074603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
    Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
    J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.
    Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M
    J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.
    Zanier K; Charbonnier S; Baltzinger M; Nominé Y; Altschuh D; Travé G
    J Mol Biol; 2005 Jun; 349(2):401-12. PubMed ID: 15890204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
    Gao Q; Kumar A; Singh L; Huibregtse JM; Beaudenon S; Srinivasan S; Wazer DE; Band H; Band V
    Cancer Res; 2002 Jun; 62(11):3315-21. PubMed ID: 12036950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation.
    Altamura G; Power K; Martano M; Degli Uberti B; Galiero G; De Luca G; Maiolino P; Borzacchiello G
    Sci Rep; 2018 Dec; 8(1):17529. PubMed ID: 30510267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
    Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
    J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.
    Talis AL; Huibregtse JM; Howley PM
    J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD.
    Tomaic V; Pim D; Thomas M; Massimi P; Myers MP; Banks L
    J Virol; 2011 Apr; 85(7):3120-7. PubMed ID: 21228227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness.
    Brimer N; Drews CM; Vande Pol SB
    PLoS Pathog; 2017 Dec; 13(12):e1006781. PubMed ID: 29281732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.
    Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K
    Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
    Thatte J; Banks L
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.